Dixon Hubard Feinour & Brown’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$419K Sell
5,234
-950
-15% -$74.3K 0.05% 209
2022
Q1
$469K Sell
6,184
-733
-11% -$58.1K 0.05% 221
2021
Q4
$590K Buy
6,917
+2,004
+41% +$156K 0.06% 198
2021
Q3
$371K Buy
4,913
+1,024
+26% +$81.3K 0.08% 137
2021
Q2
$316K Sell
3,889
-2,501
-39% -$204K 0.07% 147
2021
Q1
$498K Buy
6,390
+3,195
+100% +$250K 0.06% 152
2020
Q4
$246K Hold
3,195
0.06% 157
2020
Q3
$246K Hold
3,195
0.06% 157
2020
Q2
$242K Hold
3,195
0.06% 159
2020
Q1
$212K Hold
3,195
0.07% 148
2019
Q4
$220K Hold
3,195
0.06% 164
2019
Q3
$235K Hold
3,195
0.07% 154
2019
Q2
$229K Buy
3,195
+6
+0.2% +$426 0.07% 156
2019
Q1
$219K Buy
+3,189
New +$206K 0.07% 156
2013
Q3
Sell
-3,796
Closed -$217K 155
2013
Q2
$217K Buy
+3,796
New +$225K 0.1% 123

Other funds holding CL

Dixon Hubard Feinour & Brown's CL Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its Colgate-Palmolive (CL) stake by 15% in Q2 2022, selling an estimated $74.3K and leaving 5,234 shares worth $419K. The position accounts for 0.05% of the portfolio, ranked #209.

Dixon Hubard Feinour & Brown first reported a position in CL in Q2 2013 and has held it in 15 quarters since. The position peaked at $590K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 5,234 shares of Colgate-Palmolive worth $419K as of Q2 2022.
  • Dixon Hubard Feinour & Brown sold 950 Colgate-Palmolive shares in Q2 2022, an estimated $74.3K.
  • Colgate-Palmolive made up 0.05% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #209 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 15 quarters since.
  • Dixon Hubard Feinour & Brown's Colgate-Palmolive position peaked at $590K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.